177Lu-PSMA SPECT Quantitation at 6 Weeks (dose 2) Predicts Short Progression Free Survival for Patients Undergoing Lu PSMA I&T Therapy.
Saved in:
| Title: | 177Lu-PSMA SPECT Quantitation at 6 Weeks (dose 2) Predicts Short Progression Free Survival for Patients Undergoing Lu PSMA I&T Therapy. |
|---|---|
| Authors: | John, Nikeith1,2, Pathmanandavel, Sarennya1, Crumbaker, Megan2,3,4, Counter, William1, Bao Ho1, Yam, Andrew O.2,3,4, Wilson, Peter5, Niman, Remy5, Ayers, Maria1, Poole, Aron1, Hickey, Adam1, Agrawal, Shikha1, Perkins, Gary1, Kallinen, Annukka1, Eslick, Enid1, Stockler, Martin R.6, Joshua, Anthony M.2,3,4, Nguyen, Andrew1,2, Emmett, Louise1,2,3 louise.emmett@svha.org.au |
| Source: | Journal of Nuclear Medicine. Oct2022, Vol. 63 Issue 10, p1-25. 25p. |
| Database: | Engineering Source |
Be the first to leave a comment!
